Patient-reported outcomes following biologic therapy in a sample of adults with rheumatoid arthritis recruited from community-based rheumatologists

Arthritis Care and Research

Volumn 61, Issue 5, 2009, Pages 593-599

  Katz, Patricia ^a   Yelin, Edward ^a   Patel, Vaishali ^b   Huang, Xing Yue ^b   Chiou, Chiun Fang ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB;

ADULT; AGED; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERVIEW; JOINT STIFFNESS; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SELF REPORT; SYMPTOM; TREATMENT DURATION;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; COMMUNITY-BASED PARTICIPATORY RESEARCH; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 66249137456     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24511     Document Type: Article

References (16)

1. Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their costeffectiveness. Health Technol Assess 2006;10:1-229.
2. Finckh A, Simard J, Duryea J, Liang M, Huang J, Daneel S, et al. The effectiveness of anti-tumor necrosis factor therapy inpreventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study. Arthritis Rheum 2006;54:54-9.
3. Solomon D. The comparative safety and effectiveness of TNF-α antagonists [review]. J Manag Care Pharm 2007;13:7-18.
4. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
5. Van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, Van de Putte LBM, van Riel PLCM. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum 1996;39: 34-40.
6. Moreland L, Genovese M, Sato R, Singh A. Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis. Arthritis Rheum 2006;55:287-93.
7. Farahani P, Levine M, Gaebel K, Wang E, Khalidi N. Community-based evaluation of etanercept in patients with rheumatoid arthritis. J Rheumatol 2006;33:665-70.
8. Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and effect of anti-tumor necrosis factor therapy. J Rheumatol 2007;34:1674-83.
9. Gartlehner G, Hansen R, Jonas B, Thieda P, Lohr K. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 2006;33:2398-408.
10. Fries J, Spitz P, Kraines R, Holman H. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
11. Mason J, Anderson J, Meenan R, Haralson K, Lewis-Stevens D, Kaine J. The Rapid Assessment of Disease Activity in Rheumatology (RADAR) questionnaire: validity and sensitivity to change of a patient self-report measure of joint count and clinical status. Arthritis Rheum 1992;35:156-62.
12. Norman G, Sloan J, Wyrwich K. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. J Clin Epidemiol 2003;41:582-92.
13. Welsing P, van Gestel A, Swinkels H, Kiemeney L, van Riel P. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17.
14. Baumgartner S, Fleischmann R, Moreland L, Schiff M, Markenson J, Whitmore J. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability. J Rheumatol 2004;31: 1532-7.
15. Wolfe F, Michaud K. Fatigue, rheumatoid arthritis, and antitumor necrosis factor therapy: an investigation in 24,831 patients. J Rheumatol 2004;31:2115-20.
16. Ware JJ, Snow K, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston: Health Institute; 1993.